Lexicon Pharmaceuticals
LXRX
LXRX
122 hedge funds and large institutions have $243M invested in Lexicon Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 32 increasing their positions, 36 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
-5
Holders Change %
-3.94%
% of All Funds
1.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
32
Reduced
36
Closed
33
Calls
$805K
Puts
$145K
Net Calls
+$660K
Net Calls Change
+$354K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$36.1M |
| 2 |
SC
Sessa Capital
New York
|
$2.84M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$2.68M |
| 4 |
Millennium Management
New York
|
$1.55M |
| 5 |
Jane Street
New York
|
$761K |
Top Sellers
| 1 |
BlackRock
New York
|
$3.17M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
$4.33M |
| 3 |
State Street
Boston,
Massachusetts
|
$774K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$379K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
$2.25M |
